Professional Documents
Culture Documents
DOI 10.1007/s00125-011-2044-5
ARTICLE
Received: 21 July 2010 / Accepted: 10 December 2010 / Published online: 26 January 2011
# The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract
Aims/hypothesis Obesity is a major risk factor for type 2
diabetes. Recent genome-wide association (GWA) studies
have identified multiple loci robustly associated with BMI
and risk of obesity. However, information on their
associations with type 2 diabetes is limited. Such information could help increase our understanding of the link
between obesity and type 2 diabetes. We examined the
associations of 12 obesity susceptibility loci, individually
and in combination, with risk of type 2 diabetes in the
population-based European Prospective Investigation of
Cancer (EPIC) Norfolk cohort.
Methods We genotyped 12 SNPs, identified by GWA
studies of BMI, in 20,428 individuals (aged 3979 years
at baseline) with an average follow-up of 12.9 years, during
which 729 individuals developed type 2 diabetes. A genetic
predisposition score was calculated by adding the BMIincreasing alleles across the 12 SNPs. Associations with
incidence of type 2 diabetes were examined by logistic
regression models.
Results Of the 12 SNPs, eight showed a trend with
increased risk of type 2 diabetes, consistent with their
Introduction
777
Recent large-scale high-resolution genome-wide association (GWA) studies have identified at least 12 single
nucleotide polymorphisms (SNPs) in or near the NEGR1,
SEC16B, TMEM18, ETV5, GNPDA2, BDNF, MTCH2,
SH2B1, FAIM2, FTO, MC4R and KCTD15 genes, unequivocally associated with BMI [812]. Among these, the FTO
locus has the largest effect, with each risk allele increasing
BMI by 0.400.66 kg/m2 and obesity risk by 30%. Of
interest is that the FTO locus was first identified by a GWA
study for type 2 diabetes [8]. A more detailed examination
showed that the FTOtype 2 diabetes association was
mediated by the higher BMI observed in type 2 diabetes
cases than in controls as adjustment for BMI abolished the
association between FTO and type 2 diabetes [8]. It is not
known whether most other recently identified obesity
susceptibility loci also increase the risk of type 2 diabetes,
and whether such association is independent of, or
mediated through, BMI. Such information may increase
our understanding of the link between obesity and type 2
diabetes. After all, not all obese individuals have type 2
diabetes and vice versa. Furthermore, the collective
contribution of the obesity susceptibility variants to the
increased risk of type 2 diabetes has not been studied so far.
Thus, in the current study we examined the associations
of the 12 obesity susceptibility loci, individually and in
combination, with the risk of developing type 2 diabetes in
the European Prospective Investigation of Cancer (EPIC)
Norfolk cohort, a population-based cohort with an average
follow-up period of 12.9 years.
Methods
Study participants The EPIC-Norfolk study is a prospective population-based cohort study of 25,631 residents
living in the city of Norwich and its nearby areas. At
baseline, 21,631 individuals aged 3979 years, all of white
European origin and unrelated, had DNA available for
genotyping. Of these, we excluded (1) individuals with
missing data for any of the variables studied, including age,
sex, BMI, and genotype data for all 12 SNPs (n=629);
(2) those with an absolute annual change of BMI greater
than 2 kg/m2 or of waist circumference greater than 7 cm
during a follow-up period of 34 years (n=63); and (3)
Table 1 Characteristics of the study cohort at baseline, stratified by type 2 diabetes status
Variable
Non-case
Incident case
n
Men/women, n (%)
Age (years), mean SD
BMI (kg/m2), mean SD
19,699
9,551/10,148 (48.5/51.5)
58.69.3
26.23.7
729
450/279 (61.7/38.3)
61.88.3
29.54.3
1,220
780/440 (63.9/36.1)
62.78.2
28.94.4
778
Results
The effect sizes of individual SNPs on BMI at baseline ranged
from 0.058 to 0.328 kg/m2, with rs1121980 in the FTO locus
showing the largest effect size and rs7647305 in the ETV5
locus the smallest (Table 2). Each additional BMI-increasing
allele in the genetic predisposition score was associated with
0.153 (95% CI 0.1290.177) kg/m2 (p=5.851036) increase in BMI.
G
B
=0
.1
p= 53
5. (0.
85 12
1
9
0 3 , 0.
6
17
7)
BMI
Genetic
score
)
03
.2
,0
70 05
.1 1
(0 10
87 6
.1 6.7
=0 p=
BD
Type 2
diabetes
Nearest
gene
0.087
0.142
0.249
0.058
0.168
0.218
0.075
0.149
0.088
0.328
0.183
0.074
0.153
(0.0120.163)
(0.0480.235)
(0.1510.347)
(0.033, 0.149)
(0.0910.245)
(0.1350.301)
(0.004, 0.155)
(0.0720.225)
(0.0130.163)
(0.2520.403)
(0.0960.271)
(0.005, 0.153)
(0.1290.177)
0.023
3.04103
6.53107
0.215
1.87105
2.53107
0.064
1.42104
0.021
1.821017
3.98105
0.067
5.851036
0.992
0.919
1.148
0.879
1.110
1.077
0.995
1.022
1.039
1.086
1.079
1.062
1.040
(0.8901.106)
(0.8001.057)
(0.9891.333)
(0.774-0.999)
(0.9941.239)
(0.9551.214)
(0.8881.116)
(0.9161.141)
(0.9331.157)
(0.9751.210)
(0.9531.221)
(0.9461.192)
(1.0051.078)
1.016
1.027
1.048
1.011
1.032
1.041
1.014
1.028
1.016
1.063
1.034
1.014
1.029
(1.0021.031)
(1.0091.045)
(1.0281.067)
(0.9941.028)
(1.0171.047)
(1.0251.058)
(0.9991.029)
(1.0131.043)
(1.0021.030)
(1.0471.079)
(1.0171.051)
(0.9991.029)
(1.0241.034)
0.662
0.122
0.231
0.034
0.200
0.589
0.750
0.920
0.696
0.695
0.506
0.431
0.519
0.963
0.883
1.100
0.858
1.076
1.029
0.966
0.984
1.020
1.012
1.028
1.040
1.003
(0.8611.076)
(0.7661.018)
(0.9441.281)
(0.7530.978)
(0.9611.204)
(0.9111.164)
(0.8591.085)
(0.8801.101)
(0.9141.138)
(0.9061.130)
(0.9061.166)
(0.9241.171)
(0.9671.039)
OR (95% CI)
0.506
0.086
0.222
0.022
0.203
0.642
0.558
0.781
0.728
0.834
0.671
0.513
0.888
p value
Expected association with type 2 diabetes was calculated based on the association of the individual SNPs or the score on BMI and the association of BMI with type 2 diabetes during follow-up
0.881
0.237
0.069
0.048
0.064
0.226
0.934
0.692
0.490
0.133
0.229
0.305
0.024
p value
OR (95% CI)
a (95% CI)
p value
Regression coefficient representing the effect per risk allele on BMI, adjusted for age and sex
rs3101336
NEGR1
rs10913469
SEC16B
rs6548238
TMEM18
rs7647305
ETV5
rs10938397
GNPDA2
rs925946
BDNF
rs10838738
MTCH2
rs7132908
FAIM2
rs7498665
SH2B1
rs1121980
FTO
rs17782313
MC4R
rs368794
KCTD15
Genetic predisposition
score
SNP
Table 2 Association of individual SNPs and the genetic predisposition score with BMI and incidence of type 2 diabetes
780
Discussion
In this large population-based, prospective study with an
average follow-up period of 12.9 years, we examined
whether the recently identified BMI loci affect the risk of
type 2 diabetes independently of, or mediated through,
their effects on BMI. Despite the fact that our study was
sufficiently powered (>83%) for the majority of the
SNPs, we did not observe associations of individual
SNPs with type 2 diabetes, except for the ETV5 locus,
which showed a directionally opposite association with
type 2 diabetes (p=0.048). Although the BMI-increasing
alleles of most of the SNPs showed a directionally
consistent (increasing) trend with the risk of type 2
diabetes, adjustment for BMI attenuated this trend. The
overall genetic predisposition to obesity, as estimated by
the combination of BMI-increasing alleles across the 12
SNPs, showed an increased risk of developing type 2
diabetes. Each additional risk allele in the genetic
predisposition score was associated with a 4% increased
odds for developing type 2 diabetes during follow-up.
However, consistent with the individual SNPs analyses,
this association was mediated by the effect of the genetic
predisposition score on BMI, as adjustment for BMI
completely abolished the association. Thus, we observed
no marginal effects of the genetic predisposition score on
the risk of developing type 2 diabetes and the observed
attenuation by BMI was in line with what was expected
based on the genetic effects on BMI. Our results support
the established causal and positive association between
increased BMI and type 2 diabetes.
Information regarding the associations of individual
SNPs with type 2 diabetes might improve our understanding of the heterogeneity of the obesitytype 2 diabetes
relationship. Such heterogeneity cannot be captured by the
genetic predisposition score as it is a composite of genetic
variants that might represent a variety of biological pathways. Of the 12 loci examined in this study, only the FTO
locus was known to be associated with type 2 diabetes, but
this association is fully mediated by FTOs BMI-increasing
effect [8, 21].
Two GWA studies of BMI reported on the associations
between the identified BMI loci and the risk of type 2 diabetes
[11, 12]. In the study by Willer et al. [11], results on the
association between eight BMI loci and the risk of type 2
781
782
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K (2007)
Comparison of body mass index, waist circumference, and
waist/hip ratio in predicting incident diabetes: a meta-analysis.
Epidemiol Rev 29:115128
2. Colditz GA, Willett WC, Stampfer MJ et al (1990) Weight as a
risk factor for clinical diabetes in women. Am J Epidemiol
132:501513
3. Field AE, Coakley EH, Must A et al (2001) Impact of overweight
on the risk of developing common chronic diseases during a 10year period. Arch Intern Med 161:15811586
4. Yoon KH, Lee JH, Kim JW et al (2006) Epidemic obesity and
type 2 diabetes in Asia. Lancet 368:16811688
5. Gregg EW, Cadwell BL, Cheng YJ et al (2004) Trends in the
prevalence and ratio of diagnosed to undiagnosed diabetes
according to obesity levels in the US. Diab Care 27:28062812
6. Timpson NJ, Lindgren CM, Weedon MN et al (2009) Adiposityrelated heterogeneity in patterns of type 2 diabetes susceptibility
observed in genome-wide association data. Diabetes 58:505510
7. Cauchi S, Nead KT, Choquet H et al (2008) The genetic
susceptibility to type 2 diabetes may be modulated by obesity
status: implications for association studies. BMC Med Genet
9:45
8. Frayling TM, Timpson NJ, Weedon MN et al (2007) A common
variant in the FTO gene is associated with body mass index and
predisposes to childhood and adult obesity. Science 316:889894
9. Scuteri A, Sanna S, Chen WM et al (2007) Genome-wide
association scan shows genetic variants in the FTO gene are
associated with obesity-related traits. PLoS Genet 3:e115
10. Loos RJ, Lindgren CM, Li S et al (2008) Common variants near
MC4R are associated with fat mass, weight and risk of obesity.
Nat Genet 40:768775
11. Willer CJ, Speliotes EK, Loos RJ et al (2009) Six new loci
associated with body mass index highlight a neuronal influence on
body weight regulation. Nat Genet 41:2534
12. Thorleifsson G, Walters GB, Gudbjartsson DF et al (2009)
Genome-wide association yields new sequence variants at seven
loci that associate with measures of obesity. Nat Genet 41:1824